Study Demonstrates the Potential of HelixBind’s RaPID/BSI Assay to Accurately Identify Bloodstream Infections Associated with Sepsis in Patients Undergoing Antimicrobial Treatment
12. Februar 2024 08:30 ET
|
HelixBind
Study shows RaPID/BSI assay can accurately identify bloodstream infections associated with sepsis in patients undergoing antimicrobial treatment.
HelixBind Awarded $3MM NIH Grant to Support Testing of Its RaPID Diagnostic Platform for Invasive Infections Associated with Sepsis
17. Juni 2021 08:30 ET
|
HelixBind
BOXBOROUGH, Mass., June 17, 2021 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, announced today it...
Hospital Acquired Infections (HAI) Diagnostics Market To Reach USD 5.68 Billion By 2027 | Reports and Data
31. August 2020 19:00 ET
|
Reports and Data
New York, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The global Hospital Acquired Infections (HAI) Diagnostics market is forecast to reach USD 5.68 Billion by 2027, according to a new report by Reports and...
FDA Grants HelixBind Breakthrough Device Designation for RaPID Sepsis Test
24. August 2020 11:47 ET
|
HelixBind
BOXBOROUGH, Mass., Aug. 24, 2020 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, announced today it...
HelixBind Awarded $3MM Grant from NIH for New Rapid Test for the Early Detection of Lyme Disease
16. Juli 2020 12:01 ET
|
HelixBind
BOXBOROUGH, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for patients afflicted with invasive microbial infections,...
HelixBind Awarded $3MM Grant from NIH and Expands Clinical Advisory Board to Accelerate Development of Its Diagnostic Platform for Invasive Infections
10. Juni 2020 10:29 ET
|
HelixBind
BOXBOROUGH, Mass., June 10, 2020 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, announced today it...